SHL Telemedicine Ltd. (SWX:SHLTN)

Market Cap	39.28M +82.9%
Revenue (ttm)	50.17M +9.3%
Net Income	-12.09M
EPS	-0.39
Shares Out	37.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	717
Open	1.060
Previous Close	1.070
Day's Range	1.060 - 1.060
52-Week Range	0.700 - 1.500
Beta	-0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 9, 2026

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, provides telemedicine services in Israel, Europe, and internationally. The company offers SmartHeart platform, a 12-lead electrocardiogram (ECG) that enables a full, hospital-quality ECG to be performed by a lay-person without the assistance of a healthcare professional. It also provides preventative healthcare, including annual medical check-ups that include comprehensive laboratory tests, stress ECG tests, eye exams, and others; witness services for medical experts and medical committees;...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1986
• Employees: 526
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SHLTN

Financial Performance

In 2025, SHL Telemedicine's revenue was $58.69 million, an increase of 3.37% compared to the previous year's $56.78 million. Losses were -$15.38 million, -45.27% less than in 2024.

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 11, 2026

Data Sources Report a data error